Glaxo Probe Shows China Corruption Endemic Since Czar Execution

Glaxo Probe Shows China Corruption Endemic Since Czar Execution

Bernardo De Niz/Bloomberg

A technician works at the Pfizer Ltd. research and development plant in Dalian, China. Pfizer agreed last August to pay $60.2 million to settle foreign bribery cases it disclosed to U.S. authorities involving alleged payments paid by employees and agents of subsidiaries, including in China.